GPC5 and neoplasm: We were the first to identify a germline mutation in GPC5 (c.776C>T) among familial cases of LUAD, demonstrating that mutant GPC5 undermines the tumor-suppressive functions of GPC5. Mutational sites of GPC5 were identified through a bioinformatics database (Supplementary Figure 4).